CAD (vs. PAD) was positively associated with Fetuin-A values (OR 1.02, 95% CI 1.01–1.02; p < 0.001) and negatively with NAFLD (OR 0.16, 95% CI 0.05–0.50; p = 0.002) (Table 2). The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.